Related Experiment Video
Updated: Jun 6, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa
Ilona Carneiro1, Lucy Smith, Amanda Ross
1Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, England. ilona.carneiro@lshtm.ac.uk
Insights
Intermittent preventive treatment in infants (IPTi) effectiveness for malaria control varies by local transmission intensity and seasonality. A new tool helps policymakers assess IPTi
Area of Science:
- Malaria Control
- Public Health Policy
- Mathematical Modeling
Background:
- Intermittent preventive treatment in infants (IPTi) is a strategy to combat malaria.
- Assessing the local effectiveness of IPTi is crucial for policy decisions in sub-Saharan Africa.
- Malaria epidemiology, including transmission intensity and seasonality, significantly influences treatment efficacy.
Purpose of the Study:
- To develop a decision-support tool for policymakers in sub-Saharan Africa.
- To evaluate the potential effectiveness of IPTi for local malaria control.
Main Methods:
- Developed an algorithm combining two predictive approaches.
- Analyzed age patterns of malaria cases, admissions, and deaths based on transmission intensity and seasonality.
- Utilized a stochastic mathematical model to predict averted malaria cases under various epidemiological conditions.
Main Results:
- The proportion of malaria cases targeted by IPTi increases with outcome severity and transmission intensity.
- The decision-support tool provides context-specific estimates of targeted malaria outcomes (deaths, hospitalizations, clinical cases).
- The tool quantifies the potential number of malaria cases that could be averted by IPTi implementation.
Conclusions:
- IPTi effectiveness is contingent upon local malaria transmission intensity and seasonality.
- Local malaria epidemiology must guide decisions on IPTi implementation.
- An internet-based decision-support tool is available to predict IPTi effectiveness across diverse epidemiological settings.
Objective:
To develop a decision-support tool to help policy-makers in sub-Saharan Africa assess whether intermittent preventive treatment in infants (IPTi) would be effective for local malaria control.
Methods:
An algorithm for predicting the effect of IPTi was developed using two approaches. First, study data on the age patterns of clinical cases of Plasmodium falciparum malaria, hospital admissions for infection with malaria parasites and malaria-associated death for different levels of malaria transmission intensity and seasonality were used to estimate the percentage of cases of these outcomes that would occur in children aged <10 years targeted by IPTi. Second, a previously developed stochastic mathematical model of IPTi was used to predict the number of cases likely to be averted by implementing IPTi under different epidemiological conditions. The decision-support tool uses the data from these two approaches that are most relevant to the context specified by the user.
Findings:
Findings from the two approaches indicated that the percentage of cases targeted by IPTi increases with the severity of the malaria outcome and with transmission intensity. The decision-support tool, available on the Internet, provides estimates of the percentage of malaria-associated deaths, hospitalizations and clinical cases that will be targeted by IPTi in a specified context and of the number of these outcomes that could be averted.
Conclusion:
The effectiveness of IPTi varies with malaria transmission intensity and seasonality. Deciding where to implement IPTi must take into account the local epidemiology of malaria. The Internet-based decision-support tool described here predicts the likely effectiveness of IPTi under a wide range of epidemiological conditions.
Related Concept Videos
Malaria
Pharmacokinetics in Pediatric Patients: Drug Excretion
Respiratory Syncytial Virus Disease
Drug Dosing: Infants and Children

